<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>The Peptide Directory blog</title><description>The Peptide Directory is a source-linked peptide directory: research vendors, telehealth programs, clinics, compound guides and calculators, with every fact linked to the public source we checked and the date we checked it.</description><link>https://thepeptide.directory</link><language>en</language><item><title>Are Peptides Legal in the US? FDA Rules Explained (2026)</title><link>https://thepeptide.directory/blog/are-peptides-legal</link><guid isPermaLink="true">https://thepeptide.directory/blog/are-peptides-legal</guid><description>Approved peptides are legal with a prescription; most &apos;research peptides&apos; are unapproved drugs. How FDA approval, compounding and RUO labels fit together.</description><pubDate>Mon, 19 Oct 2026 00:00:00 GMT</pubDate><category>Guides</category></item><item><title>Bacteriostatic Water for Peptides: Uses &amp; How Much to Add</title><link>https://thepeptide.directory/blog/bacteriostatic-water-guide</link><guid isPermaLink="true">https://thepeptide.directory/blog/bacteriostatic-water-guide</guid><description>Bacteriostatic water is sterile water with 0.9% benzyl alcohol for multi-dose vials. What the label says, how volume sets concentration, and the math.</description><pubDate>Mon, 19 Oct 2026 00:00:00 GMT</pubDate><category>Guides</category></item><item><title>FDA Advisers Back BPC-157 Compounding: 8–6 Vote Explained</title><link>https://thepeptide.directory/blog/fda-advisory-vote-bpc-157-compounding-2026</link><guid isPermaLink="true">https://thepeptide.directory/blog/fda-advisory-vote-bpc-157-compounding-2026</guid><description>On July 23, 2026 FDA advisers voted 8–6 to recommend BPC-157, TB-500 and KPV for the 503A bulks list. The vote is non-binding; compounding isn&apos;t legal yet.</description><pubDate>Mon, 19 Oct 2026 00:00:00 GMT</pubDate><category>News</category></item><item><title>How to Read a Peptide Certificate of Analysis (COA)</title><link>https://thepeptide.directory/blog/how-to-read-a-peptide-certificate-of-analysis</link><guid isPermaLink="true">https://thepeptide.directory/blog/how-to-read-a-peptide-certificate-of-analysis</guid><description>A peptide COA should name the lab, lot number, test date, method and result. Here are six checks for HPLC purity, mass-spec identity, endotoxin and lot matching.</description><pubDate>Mon, 19 Oct 2026 00:00:00 GMT</pubDate><category>Guides</category></item><item><title>How to Store Peptides: Fridge, Freezer &amp; Room Temperature</title><link>https://thepeptide.directory/blog/how-to-store-peptides</link><guid isPermaLink="true">https://thepeptide.directory/blog/how-to-store-peptides</guid><description>What FDA labels say about storing peptide drugs like Wegovy and Zepbound, and what that implies for powdered and reconstituted research peptides.</description><pubDate>Mon, 19 Oct 2026 00:00:00 GMT</pubDate><category>Guides</category></item><item><title>Retatrutide Phase 3 Results (2026): TRIUMPH-2 and TRIUMPH-3</title><link>https://thepeptide.directory/blog/retatrutide-triumph-phase-3-results-2026</link><guid isPermaLink="true">https://thepeptide.directory/blog/retatrutide-triumph-phase-3-results-2026</guid><description>Lilly reported up to 20.8% weight loss in TRIUMPH-2 and 22.6% in TRIUMPH-3 at 80 weeks on retatrutide 12 mg. Still investigational; a BLA is planned for Q1 2027.</description><pubDate>Mon, 19 Oct 2026 00:00:00 GMT</pubDate><category>Research</category></item><item><title>Semaglutide Dosage: Wegovy Injection and Tablet Schedules</title><link>https://thepeptide.directory/blog/semaglutide-dosage</link><guid isPermaLink="true">https://thepeptide.directory/blog/semaglutide-dosage</guid><description>Wegovy injection: 0.25 mg weekly, rising to 0.5, 1 and 1.7 mg, then 2.4 mg from week 17; 7.2 mg is optional. Tablets reach 25 mg daily by day 91.</description><pubDate>Mon, 19 Oct 2026 00:00:00 GMT</pubDate><category>Guides</category></item><item><title>Semaglutide Side Effects: Wegovy Label Rates (2026)</title><link>https://thepeptide.directory/blog/semaglutide-side-effects</link><guid isPermaLink="true">https://thepeptide.directory/blog/semaglutide-side-effects</guid><description>On Wegovy 2.4 mg, 44% had nausea vs 16% on placebo, and 73% had a GI effect. Label rates for each common side effect, the serious warnings and the gaps.</description><pubDate>Mon, 19 Oct 2026 00:00:00 GMT</pubDate><category>Guides</category></item><item><title>Third-Party Peptide Testing: Janoshik, Chromate &amp; COA Labs</title><link>https://thepeptide.directory/blog/third-party-peptide-testing</link><guid isPermaLink="true">https://thepeptide.directory/blog/third-party-peptide-testing</guid><description>Which outside labs peptide vendors name (Janoshik, Vanguard, Freedom Diagnostics, Chromate and more), what their tests show and what they cannot prove.</description><pubDate>Mon, 19 Oct 2026 00:00:00 GMT</pubDate><category>Guides</category></item><item><title>Tirzepatide Dosage: Zepbound Label Schedule, Step by Step</title><link>https://thepeptide.directory/blog/tirzepatide-dosage</link><guid isPermaLink="true">https://thepeptide.directory/blog/tirzepatide-dosage</guid><description>Zepbound starts at 2.5 mg weekly for 4 weeks, then 5 mg, rising 2.5 mg at least 4 weeks apart to a 5, 10 or 15 mg maintenance dose. Label-sourced.</description><pubDate>Mon, 19 Oct 2026 00:00:00 GMT</pubDate><category>Guides</category></item><item><title>Tirzepatide Side Effects by Dose: Zepbound Label (2026)</title><link>https://thepeptide.directory/blog/tirzepatide-side-effects</link><guid isPermaLink="true">https://thepeptide.directory/blog/tirzepatide-side-effects</guid><description>Nausea hit 25–29% of Zepbound users vs 8% on placebo; most GI effects came during dose escalation. Every rate below is from the FDA label, with the source linked.</description><pubDate>Mon, 19 Oct 2026 00:00:00 GMT</pubDate><category>Guides</category></item><item><title>Wegovy HD 7.2 mg Approved: Who It&apos;s For and How It Fits</title><link>https://thepeptide.directory/blog/wegovy-hd-7-2mg-approval</link><guid isPermaLink="true">https://thepeptide.directory/blog/wegovy-hd-7-2mg-approval</guid><description>FDA approved Wegovy HD (semaglutide 7.2 mg weekly) on March 19, 2026 for adults who have tolerated 2.4 mg for at least 4 weeks and need more weight loss.</description><pubDate>Mon, 19 Oct 2026 00:00:00 GMT</pubDate><category>News</category></item><item><title>What &quot;Research Use Only&quot; Means on Peptide Websites</title><link>https://thepeptide.directory/blog/what-research-use-only-means</link><guid isPermaLink="true">https://thepeptide.directory/blog/what-research-use-only-means</guid><description>&quot;Research use only&quot; means a product is not for human or veterinary use and is not made or reviewed as a drug. What that implies for quality and legality.</description><pubDate>Mon, 19 Oct 2026 00:00:00 GMT</pubDate><category>Guides</category></item><item><title>Wolverine Stack (BPC-157 + TB-500): What the Evidence Shows</title><link>https://thepeptide.directory/blog/wolverine-stack-bpc-157-tb-500</link><guid isPermaLink="true">https://thepeptide.directory/blog/wolverine-stack-bpc-157-tb-500</guid><description>The wolverine stack pairs BPC-157 and TB-500 for injury recovery. Neither is FDA-approved, both are banned in sport, and no study has tested the pair.</description><pubDate>Mon, 19 Oct 2026 00:00:00 GMT</pubDate><category>Research</category></item></channel></rss>